Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVS - BioCryst Pharmaceuticals: BCX9930's Competitive Profile In PNH Patients

NVS - BioCryst Pharmaceuticals: BCX9930's Competitive Profile In PNH Patients

Novartis AG
  • BioCryst recently reported additional results of BCX9930 in PNH patients naïve to C5 inhibitors.
  • The results were not perfect but seem good enough to support further development.
  • BCX9930's value proposition goes far beyond PNH, and diseases other than PNH hold the real potential for value creation in the following years.
  • There are very strong competitors in the complement space and other approaches are interesting as well.

For further details see:

BioCryst Pharmaceuticals: BCX9930's Competitive Profile In PNH Patients
Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...